CDT Equity Inc.
No SEC Form 4 filings for $CDT in the last 30 days.
See all $CDT insider activity →CDT Equity raised $6.75 million via a senior secured convertible note from J.J. Astor, with 24 weekly payments starting Oct 14, 2026. The note matures Mar 24, 2027, and is convertible at 70% of the lowest 20-day closing price or a $0.18354 floor. The company also issued 225,000 warrants priced at $0.9177, subject to Nasdaq approval by Nov 13, 2026.
CDT Equity Inc. (CDT) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Senior Secured Convertible Promissory Note to J.J. Astor & Co. On October 6, 2026, CDT Equity Inc. (the “Company”) issued a senior secured convertible note (the “Note”) to J.J. Astor & Co. (the “Lender”), in the principal amou
CDT Equity Inc. (Nasdaq: CDT) announced a 1-for-25 reverse stock split, effective September 28, 2026, to comply with Nasdaq's bid-price rule. The split will reduce outstanding shares to approximately 1,013,515, with trading continuing under the same ticker symbol. The company is a data-driven biopharmaceutical firm focused on therapeutic asset development.
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning CDT (CDT Equity Inc.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 2 bearish.
Recent CDT coverage spans corporate actions, market movers and insider activity.
The convertible note adds liquidity but introduces dilution risk; the note’s conversion terms could pressure the share price if the stock trades below the conversion floor.
The financing terms are likely dilutive and increase near-term overhang risk, while the second tranche conditions create a binary catalyst around late-2026 approvals and bid-price compliance.
The reverse split will reduce shares outstanding to ~1.0M, potentially boosting share price and liquidity.
The reverse split will reduce share count and likely cause short-term price volatility as the market adjusts the new share structure.
The new convertible note creates a senior secured debt obligation and potential dilution if converted, likely pressuring the stock short‑term.
AlphAI scores every news story that mentions CDT with an AI model for sentiment and relevance, and aggregates insider trades from CDT Equity Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
CDT Equity raised $6.75 million via a senior secured convertible note from J.J. Astor, with 24 weekly payments starting Oct 14, 2026. The note matures Mar 24, 2027, and is convertible at 70% of the lowest 20-day closing price or a $0.18354 floor. The company also issued 225,000 warrants priced at $0.9177, subject to Nasdaq approval by Nov 13, 2026.
2 min readCDT Equity Inc. (CDT) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Senior Secured Convertible Promissory Note to J.J. Astor & Co. On October 6, 2026, CDT Equity Inc. (the “Company”) issued a senior secured convertible note (the “Note”) to J.J. Astor & Co. (the “Lender”), in the principal amou
6 min readCDT Equity Inc. (Nasdaq: CDT) announced a 1-for-25 reverse stock split, effective September 28, 2026, to comply with Nasdaq's bid-price rule. The split will reduce outstanding shares to approximately 1,013,515, with trading continuing under the same ticker symbol. The company is a data-driven biopharmaceutical firm focused on therapeutic asset development.
2 min readCDT Equity Inc. (CDT) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 CDT Equity Inc. Announces Reverse Stock Split NAPLES, Fla. and CAMBRIDGE, United Kingdom, September 25, 2026 (GLOBE NEWSWIRE) — CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), announces that its board of directors has approved a 1-for-25 reverse stock split o
1 min readCDT Equity Inc. (CDT) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Senior Secured Convertible Promissory Note to J.J. Astor & Co. On September 14, 2026, CDT Equity Inc. (the “Company”) issued a senior secured convertible promissory note (the “Note”) to J.J. Astor & Co. (the “Lender”), in the
1 min readCDT Equity Inc. (CDT) fell 37% to $0.3783 on Thursday, despite announcing Sarborg's drug discovery advancements. CDT owns 22.7% of Sarborg, valued at $709M. Trading volume surged to 34.03M shares. CDT's 52-week range is $0.3641 to $2,360.00.
1 min readCDT Equity Inc. (CDT) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Amended Securities Purchase Agreement with Sarborg Limited On August 31, 2026, CDT Equity Inc. (the “Company”) entered into an amendment (the “Amendment”) to the Securities Purchase Agreement, dated February 19, 2026 (as amend
1 min readRegan Andrew (Chief Executive Officer) sold 290 indirectly-held shares of CDT Equity Inc. (CDT) on 2026-08-28.
1 min readCDT Equity Inc. (CDT) named co-founder James Bligh as CEO. Bligh has extensive experience in corporate finance and M&A. The company has recently strengthened its balance sheet and made strategic investments. CDT shares fell 4.76% in pre-market trading to $1.60, following a 0.59% decline the prior day.
1 min readCDT Equity Inc. (CDT) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of James Bligh On August 31, 2026 (the “Effective Date”), CDT Equity Inc (the “Company”) appointed Mr. James Bl
2 min read
